Roswell Biotechnologies, the molecular electronics company, announced that Chief Science Officer Barry Merriman, Ph.D. presented a paper titled “A CMOS Molecular Electronics Chip for Single-Molecule Biosensing” at the prestigious International Solid-State Circuits Conference (ISSCC) on Feb. 22.
The presentation detailed the design of the Roswell Molecular Electronics (ME) Chip™, the first commercial molecular electronics chip. The Roswell Molecular Electronics Platform has also been chosen for the highly selective conference live-demo session.
The Roswell ME Chip integrates single bio-molecules as sensor elements in nano-electrode circuits on a semiconductor (CMOS) chip. This provides an all-electronic, programmable biosensor with real-time, single-molecule sensitivity and unlimited capacity to scale the sensor array density. A peer-reviewed paper recently appeared in the Proceedings of the National Academy of Sciences detailing its diverse biosensing applications.
“It is an honor to have our molecular electronics chip recognized at this conference as one of the most innovative new chips,” Merriman said. “The ISSCC is where the top chipmakers—like Intel, Samsung, and NVIDIA—present their latest work and where the most exciting new chips are introduced, such as the Intel Bitcoin mining chip and the Google Quantum computing chip. To be selected to present our peer-reviewed paper and demo alongside these top chipmakers highlights that we are doing something truly new, integrating single molecules into the circuits as sensors.”
